-+ 0.00%
-+ 0.00%
-+ 0.00%

Piper Sandler Initiates Coverage On Obsidian Therapeutics with Overweight Rating, Announces Price Target of $42

Benzinga·08/05/2026 10:13:42
Listen to the news
Piper Sandler analyst Kelsey Goodwin initiates coverage on Obsidian Therapeutics (NASDAQ:OBX) with a Overweight rating and announces Price Target of $42.